Newsroom

Nothing to sniff at: Screening platform identifies drugs that could fight the common cold


January 10, 2020

“We’re getting closer to finding a drug that can stop a cold virus in its tracks,” -Dr. Robin Parks, senior scientist at The Ottawa Hospital, professor at the University of Ottawa.A team led by Dr. Robin Parks has developed a new way to identify drugs that may be good candidates for treating the common cold. While many products can treat cold symptoms, there is currently no way to treat the viruses that causes the disease, such as the adenovirus. 

The average person has around 400 colds in their lifetime, accounting for 40 percent of all workplace absenteeism. Colds can also be dangerous for those with compromised immune systems, or the very young or the very old – adenovirus is responsible for at least 100 deaths in Canada every year. 

The research team designed a small molecule screening platform and used it to test 1,200 drugs used to treat other conditions. They found 11 drugs that kept the cold-causing adenovirus from replicating, including cardiotonic steroids, corticosteroids and chemotherapy agents. Next they will investigate exactly how these drugs are stopping the virus. The team’s ultimate goal is a treatment that makes a cold less severe and prevents it from spreading.

“We’re getting closer to finding a drug that can stop a cold virus in its tracks,” said Dr. Robin Parks, senior scientist at The Ottawa Hospital, professor at the University of Ottawa.

Source: Virology

Authors: Bratati Saha, Oliver Varette, William L Stanford, Jean-Simon Diallo, Robin J Parks

Funding: Canadian Institute of Health Research, Natural Sciences and Engineering Research Council of Canada. Research at The Ottawa Hospital is possible because of generous donations to The Ottawa Hospital Foundation

Core resources: High Content Imaging Core

 

The Ottawa Hospital: Inspired by research. Driven by compassion 

The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care. See www.ohri.ca for more information about research at The Ottawa Hospital.

University of Ottawa: —A crossroads of cultures and ideas

The University of Ottawa is home to over 50,000 students, faculty and staff, who live, work and study in both French and English. Our campus is a crossroads of cultures and ideas, where bold minds come together to inspire game-changing ideas. We are one of Canada’s top 10 research universities—our professors and researchers explore new approaches to today’s challenges. One of a handful of Canadian universities ranked among the top 200 in the world, we attract exceptional thinkers and welcome diverse perspectives from across the globe. www.uottawa.ca

Media Contact

Amelia Buchanan
Senior Communication Specialist
Ottawa Hospital Research Institute
Office: 613-798-5555 x 73687
Cell: 613-297-8315
ambuchanan@ohri.ca

 

Disease and research area tags: Common cold, Infectious disease

Scientific Program tags: Regenerative Medicine Program